End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
91.8 TWD | +0.99% | -12.57% | +122.28% |
May. 13 | Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Easywell Biomedicals, Inc. announced a financing transaction | CI |
Sales 2022 | 179M 5.52M | Sales 2023 | 272M 8.37M | Capitalization | 4.79B 148M |
---|---|---|---|---|---|
Net income 2022 | -161M -4.96M | Net income 2023 | -145M -4.47M | EV / Sales 2022 | 10.3 x |
Net Debt 2022 | 10.42M 321K | Net Debt 2023 | 38.31M 1.18M | EV / Sales 2023 | 17.8 x |
P/E ratio 2022 |
-11.4
x | P/E ratio 2023 |
-32.6
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 43.58% |
1 day | +0.99% | ||
1 week | -12.57% | ||
1 month | +30.58% | ||
3 months | +67.52% | ||
6 months | +129.50% | ||
Current year | +122.28% |
Managers | Title | Age | Since |
---|---|---|---|
Ai Ping Lee
CEO | Chief Executive Officer | - | 14-08-31 |
Hsueh Chun Wu
DFI | Director of Finance/CFO | - | - |
Howard Lee
BRD | Director/Board Member | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jy Gang Ger
BRD | Director/Board Member | - | 16-06-22 |
Chih Cheng Chang
BRD | Director/Board Member | - | 13-10-24 |
Han Fei Lin
CHM | Chairman | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 91.8 | +0.99% | 342,819 |
24-05-30 | 90.9 | -3.81% | 811,076 |
24-05-29 | 94.5 | -5.50% | 829,079 |
24-05-28 | 100 | -.--% | 489,284 |
24-05-27 | 100 | -4.76% | 787,255 |
End-of-day quote Taipei Exchange, May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+122.28% | 344M | |
+40.73% | 739B | |
+31.81% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.45% | 240B | |
+9.32% | 210B | |
-5.03% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 1799 Stock